Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS)-Reference-Cited by-同舟云学术

Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS)

Published:2022-07 Issue:7 Volume:12 Page:
ISSN:2045-7022
Container-title:Clinical and Translational Allergy
language:en
Short-container-title:Clinical & Translational All

Author:

Szefler Stanley J.¹,Roberts Graham²³^ORCID,Rubin Adalberto S.⁴,Zielen Stefan⁵,Kuna Piotr⁶,Alpan Oral⁷,Anzures‐Cabrera Judith⁸,Chen Qiang⁹,Holweg Cécile T. J.¹⁰,Kaminski Janusz⁸,Putnam Wendy S.¹⁰,Matthews John G.¹⁰,Kamath Nikhil⁸

Affiliation:

1. Department of Pediatrics Children's Hospital Colorado and the University of Colorado School of Medicine Anschutz Medical Campus Aurora Colorado USA

2. University of Southampton School of Medicine and Southampton Biomedical Research Centre University Hospital Southampton NHS Foundation Trust Southampton UK

3. David Hide Asthma and Allergy Research Centre Isle of Wight UK

4. Federal University of Health Sciences of Porto Alegre and Santa Casa de Misericórdia Hospital Porto Alegre Brazil

5. Goethe‐Universität Klinik für Kinder‐ und Jugendmedizin Frankfurt Germany

6. Medical University of Łódź Lodz Poland

7. O&O Alpan LLC Fairfax Virginia USA

8. Roche Products Ltd Welwyn Garden City UK

9. Roche (China) Holding Ltd Shanghai China

10. Genentech, Inc. South San Francisco California USA

Funder

Roche Products

Genentech

Publisher

Wiley

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clt2.12176

Reference30 articles.

1. Global Initiative for Asthma.GINA Report: Pocket Guide for Asthma Management and Prevention;2020. Accessed 3 April 2020.https://ginasthma.org/wp‐content/uploads/2020/04/Main‐pocket‐guide_2020_04_03‐final‐wms.pdf

2. Global Asthma Network.The Global Asthma Report 2018;2018. Accessed 1 May 2019.http://globalasthmareport.org/

3. Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma

4. Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic monoclonal antibodies in allergy: Targeting IgE, cytokine, and alarmin pathways;Immunological Reviews;2024-08-19

2. Asma grave: fisiopatología, diagnóstico y tratamiento;Revista Alergia México;2024-06-30

3. Role of IL‐5 in asthma and airway remodelling;Clinical & Experimental Allergy;2024-06-27

4. Monoclonal antibodies for moderate-to-severe atopic dermatitis: a look at phase III and beyond;Expert Opinion on Biological Therapy;2024-06-02

5. Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population;The Journal of Allergy and Clinical Immunology: In Practice;2024-05